RxDoctor Payments Data

Oluyemisi Sangodeyi, MD

Surgery · Beckley, WVNPI 1487651717

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (42.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Intuitive Surgical at 56.3% of the total. Reporting peaked in 2019 at $6,541 and has fallen 92.1% since, to $516 in 2025.

$9,495in general payments, 2019–2025

Across 117 payments — averaging $81.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$5K
  • Organogenesis Inc.$793
  • Titan Pharmaceuticals, Inc.$603
  • Indivior Inc.$357
  • Smith+Nephew$225
  • Melinta Therapeutics, LLC$223
  • plus $2K from 20 others

What the payments were for

  • Travel & lodging$1,76619%
  • Food & beverage$3,72939%
  • Education$4,00042%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,495 in reported general payments places this provider in the 85th percentile of 162 surgery providers in West Virginia.

See all surgery providers in West Virginia

Medicare billing

Part B allowed, 2024
$116,250
Medicare patients
239
Services billed
1,222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide14$12,925
SantylCollagenase Clostridium Hist.23$9,968
EliquisApixaban11$8,460
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl26$1,174
Ondansetron OdtOndansetron30$840
Gabapentin85$719
Albuterol Sulfate HfaAlbuterol Sulfate32$705
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen63$576
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav44$507
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen34$298
Duloxetine Hcl22$267
Tramadol Hcl22$200
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine12$195
Ciprofloxacin Hcl29$189
Pantoprazole Sodium21$157

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$225$9,96823 claims
PfizerEliquis$169$8,46011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 162 surgery providers in West Virginia.

Other surgery in Beckley

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →